Wednesday, March 28, 2018

Federal Register :: Agency Information Collection Activities ...
5 hours ago - FDA Response to Issue One: Under section 503B(d)(2), if a drug is not identical or nearly identical to an approved drug or a covered over-the-counter monograph (OTC) drug, and a component of the compounded drug is a bulk drug substance that is a component of an approved drug or a covered OTC drug, then the drug is ..

No comments: